MAI Capital Management’s Trevi Therapeutics TRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$777K Sell
65,125
-12,644
-16% -$142K ﹤0.01% 860
2025
Q4
$974K Sell
77,769
-20,723
-21% -$239K 0.01% 744
2025
Q3
$901K Sell
98,492
-749,061
-88% -$5.62M 0.01% 740
2025
Q2
$4.64M Sell
847,553
-537,497
-39% -$3.34M 0.03% 344
2025
Q1
$8.71M Buy
1,385,050
+28,164
+2% +$134K 0.07% 243
2024
Q4
$5.59M Buy
1,356,886
+29,601
+2% +$94.8K 0.04% 312
2024
Q3
$4.43M Buy
1,327,285
+8,789
+0.7% +$26.1K 0.04% 273
2024
Q2
$3.93M Buy
1,318,496
+186,675
+16% +$519K 0.04% 293
2024
Q1
$3.9M Sell
1,131,821
-147,637
-12% -$329K 0.04% 287
2023
Q4
$1.71M Sell
1,279,458
-171,942
-12% -$260K 0.02% 351
2023
Q3
$3.16M Sell
1,451,400
-83,252
-5% -$188K 0.05% 238
2023
Q2
$3.67M Sell
1,534,652
-65,763
-4% -$166K 0.05% 221
2023
Q1
$2.96M Sell
1,600,415
-120,261
-7% -$272K 0.05% 237
2022
Q4
$3.32M Sell
1,720,676
-298,488
-15% -$588K 0.06% 216
2022
Q3
$3.11M Sell
2,019,164
-20,845
-1% -$68.3K 0.06% 210
2022
Q2
$5.73M Buy
2,040,009
+498,538
+32% +$1.22M 0.11% 150
2022
Q1
$3.39M Buy
+1,541,471
New +$1.6M 0.06% 194

Other funds holding TRVI